Cargando…
Activity of Selected Group of Monoterpenes in Alzheimer’s Disease Symptoms in Experimental Model Studies—A Non-Systematic Review
Alzheimer’s disease (AD) is the leading cause of dementia and cognitive function impairment. The multi-faced character of AD requires new drug solutions based on substances that incorporate a wide range of activities. Antioxidants, AChE/BChE inhibitors, BACE1, or anti-amyloid platelet aggregation su...
Autores principales: | Wojtunik-Kulesza, Karolina, Rudkowska, Monika, Kasprzak-Drozd, Kamila, Oniszczuk, Anna, Borowicz-Reutt, Kinga |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8306454/ https://www.ncbi.nlm.nih.gov/pubmed/34298986 http://dx.doi.org/10.3390/ijms22147366 |
Ejemplares similares
-
Toxicity of Selected Monoterpenes and Essential Oils Rich in These Compounds
por: Wojtunik-Kulesza, Karolina A.
Publicado: (2022) -
Approach to Optimization of FRAP Methodology for Studies Based on Selected Monoterpenes
por: Wojtunik-Kulesza, Karolina A.
Publicado: (2020) -
The Efficacy of Black Chokeberry Fruits against Cardiovascular Diseases
por: Kasprzak-Drozd, Kamila, et al.
Publicado: (2021) -
Aducanumab—Hope or Disappointment for Alzheimer’s Disease
por: Wojtunik-Kulesza, Karolina, et al.
Publicado: (2023) -
Selected Natural Products in Neuroprotective Strategies for Alzheimer’s Disease—A Non-Systematic Review
por: Wojtunik-Kulesza, Karolina, et al.
Publicado: (2022)